Company · Saint-Hubert, Quebec, Canada
Sandoz Canada Inc.
Everything this company holds in Health Canada’s product databases, as the company’s name is spelled there.
- Drug products (DIN)
- 1,065
- 583 authorized now
- Natural health products
- 59
- 10 active licences
- Medical device licences
- 0
- 0 active
- Notices of Compliance
- 1,405
Drug products
Authorized products first.
Showing 300 of 1,065 drug products. For the rest, search Health Canada’s database.
Natural health products
Active licences first, newest first.
| Name | NPN | Status | Licensed |
|---|---|---|---|
| Sandoz Hydrocortisone 1% | 02412926 | Active | |
| Carbocal D 500/1000 | 80027625 | Active | |
| Sandoz Sodium Bicarbonate | 80022194 | Active | |
| Carbocal D 400 | 02245511 | Active | |
| Euro K 20 | 02242261 | Active | |
| Euro-Fer | 02237556 | Active | |
| Euro K 600 | 02246734 | Active | |
| Sandoz Senna | 02247389 | Active | |
| Sandoz D 1000 | 80003707 | Active | |
| Ci-Cal D 400 | 80000281 | Active | |
| Koena Woman Daily | 80085729 | Discontinued | |
| Koena Kids Acute Care | 80078306 | Discontinued | |
| Revitonus Ultra | 80075535 | Discontinued | |
| Exoderil Nailner Brush 2 in 1 | 80072129 | Discontinued | |
| Exoderil Nailner Spray | 80071827 | Discontinued | |
| Exoderil Nailner Pen 2.0 | 80070891 | Discontinued | |
| UNPLUGGED SALINEX | 80070469 | Discontinued | |
| Polytopic | 80065342 | Discontinued | |
| Cebolixs | 80065173 | Discontinued | |
| Sandoz B12 LA | 80061573 | Discontinued | |
| Ezeva | 80061236 | Discontinued | |
| Ezeva | 80061269 | Discontinued | |
| Ezeva | 80061235 | Discontinued | |
| Glycerin Suppositories | 80052812 | Discontinued | |
| Glycerin Suppositories | 80052814 | Discontinued | |
| ONYPEN | 80043791 | Discontinued | |
| Cebolixs | 80041856 | Discontinued | |
| Hemarexin+C1000 | 80037785 | Discontinued | |
| Ci-Cal D 1000 | 80032607 | Discontinued | |
| Anuzinc | 80032266 | Discontinued | |
| Acti-B12 | 80031423 | Discontinued | |
| Ci-Cal D 250/200 | 80030816 | Discontinued | |
| Salinex Nasal Lubricant Gel | 80029623 | Discontinued | |
| Hemarexin | 80029250 | Discontinued | |
| Diamine | 80028781 | Discontinued | |
| Hormodausse | 80027544 | Discontinued | |
| Transderm-V | 80024336 | Discontinued | |
| Sandoz Sennosides 12 mg | 80024170 | Discontinued | |
| Sandoz Sennosides 8.6 mg | 80024148 | Discontinued | |
| Sandoz Sodium Chloride | 80023725 | Discontinued | |
| Revitonus C-1000 | 80020988 | Discontinued | |
| Tablet of Vitamin C 500mg | 80020991 | Discontinued | |
| Sandoz Calcium 500 mg + D 400 IU | 80019239 | Discontinued | |
| CiCal D | 80013612 | Discontinued | |
| Euro K 975 | 80011428 | Discontinued | |
| Ci-Cal | 02238273 | Discontinued | |
| Ferrate | 02246590 | Discontinued | |
| Euro Vitamin B1 50mg | 02245506 | Discontinued | |
| Sandoz D 400 | 02242651 | Discontinued | |
| Eurocal D | 02237351 | Discontinued | |
| EUROCAL | 02237352 | Discontinued | |
| Forza 10 | 02241568 | Discontinued | |
| Zoderm | 02244952 | Discontinued | |
| Sandoz Fer CF | 02241802 | Discontinued | |
| Euro-Ferrous Sulfate | 02246733 | Discontinued | |
| Carbocal D 400 | 80004545 | Discontinued | |
| Sandoz-D 800 | 80003010 | Discontinued | |
| Carbocal D 400 (Chewable tablet) | 80002901 | Discontinued | |
| EURO-FOLIC | 80000695 | Discontinued |
Notices of Compliance
Newest first.
- SANDOZ CANDESARTAN PLUSOctober 8, 2026 · NOC 38438 · Supplement to an Abbreviated New Drug Submission (SANDS)
- SANDOZ DORZOLAMIDE/TIMOLOLOctober 7, 2026 · NOC 38426 · Supplement to an Abbreviated New Drug Submission (SANDS)
- SANDOZ METFORMIN FCOctober 5, 2026 · NOC 38412 · Supplement to an Abbreviated New Drug Submission (SANDS)
- HALOPERIDOL LASeptember 24, 2026 · NOC 38341 · Supplement to a New Drug Submission (SNDS)
- SANDOZ CLONIDINESeptember 24, 2026 · NOC 38350 · Supplement to an Abbreviated New Drug Submission (SANDS)
- SANDOZ SEMAGLUTIDESeptember 16, 2026 · NOC 38299 · Abbreviated New Drug Submission (ANDS)
- STALEVOSeptember 2, 2026 · NOC 38234 · Supplement to a New Drug Submission (SNDS)
- CLINDAMYCIN INJECTION USPAugust 27, 2026 · NOC 38198 · Supplement to an Abbreviated New Drug Submission (SANDS)
- SANDOZ APIXABAN TABLETAugust 20, 2026 · NOC 38149 · Supplement to an Abbreviated New Drug Submission (SANDS)
- CLINDAMYCIN IV INFUSIONAugust 20, 2026 · NOC 38168 · Supplement to a New Drug Submission (SNDS)
- SANDOZ VORICONAZOLE; VORICONAZOLE FOR INJECTIONJuly 24, 2026 · NOC 37985 · Supplement to an Abbreviated New Drug Submission (SANDS)
- SANDOZ VALACYCLOVIRJuly 24, 2026 · NOC 37988 · Supplement to an Abbreviated New Drug Submission (SANDS)
- SANDOZ LEVETIRACETAMJuly 21, 2026 · NOC 37962 · Supplement to an Abbreviated New Drug Submission (SANDS)
- SANDOZ ANASTROZOLEJuly 21, 2026 · NOC 37963 · Supplement to an Abbreviated New Drug Submission (SANDS)
- SANDOZ FENOFIBRATE EJuly 20, 2026 · NOC 37947 · Supplement to an Abbreviated New Drug Submission (SANDS)
- SANDOZ FELODIPINEJuly 16, 2026 · NOC 37924 · Supplement to an Abbreviated New Drug Submission (SANDS)
- SANDOZ SITAGLIPTINJuly 16, 2026 · NOC 37942 · Supplement to an Abbreviated New Drug Submission (SANDS)
- SANDOZ ROSUVASTATINJuly 13, 2026 · NOC 37905 · Supplement to an Abbreviated New Drug Submission (SANDS)
- TOBRAMYCIN INJECTION USPJuly 7, 2026 · NOC 37853 · Supplement to an Abbreviated New Drug Submission (SANDS)
- SANDOZ IRBESARTAN HCTJuly 3, 2026 · NOC 37824 · Supplement to an Abbreviated New Drug Submission (SANDS)
- DILTIAZEM HYDROCHLORIDE INJECTIONJuly 2, 2026 · NOC 37822 · Supplement to an Abbreviated New Drug Submission (SANDS)
- AMIKACIN SULFATE INJECTION USPJune 26, 2026 · NOC 37787 · Supplement to an Abbreviated New Drug Submission (SANDS)
- SANDOZ TACROLIMUSJune 26, 2026 · NOC 37801 · Supplement to an Abbreviated New Drug Submission (SANDS)
- SANDOZ SACUBITRIL-VALSARTANJune 23, 2026 · NOC 37753 · Supplement to a New Drug Submission (SNDS)
- ENZEEVUJune 16, 2026 · NOC 37720 · Supplement to a New Drug Submission (SNDS)
- CLINDAMYCIN INJECTION USPJune 16, 2026 · NOC 38137 · Supplement to an Abbreviated New Drug Submission (SANDS)
- SANDOZ MIGLUSTATJune 12, 2026 · NOC 37705 · Supplement to an Abbreviated New Drug Submission (SANDS)
- SANDOZ TOFACITINIBJune 10, 2026 · NOC 37695 · Supplement to an Abbreviated New Drug Submission (SANDS)
- SANDOZ TACROLIMUSJune 9, 2026 · NOC 37682 · Supplement to an Abbreviated New Drug Submission (SANDS)
- SANDOZ LEFLUNOMIDEMay 29, 2026 · NOC 37654 · Supplement to an Abbreviated New Drug Submission (SANDS)
- CIPROFLOXACIN INTRAVENOUS INFUSION BP; SANDOZ CIPROFLOXACINMay 26, 2026 · NOC 37613 · Supplement to an Abbreviated New Drug Submission (SANDS)
- OXALIPLATIN INJECTIONMay 19, 2026 · NOC 37577 · Supplement to an Abbreviated New Drug Submission (SANDS)
- SANDOZ MYCOPHENOLATE MOFETILMay 14, 2026 · NOC 37543 · Supplement to an Abbreviated New Drug Submission (SANDS)
- MICRO IMay 13, 2026 · NOC 37536 · Supplement to a New Drug Submission (SNDS)
- SANDOZ FESOTERODINE FUMARATEMay 13, 2026 · NOC 37549 · Supplement to an Abbreviated New Drug Submission (SANDS)
- ENZEEVUMay 7, 2026 · NOC 37500 · Supplement to a New Drug Submission (SNDS)
- ZIEXTENZOMay 7, 2026 · NOC 37510 · Supplement to a New Drug Submission (SNDS)
- PROPRANOLOL HYDROCHLORIDE INJECTION USPMay 7, 2026 · NOC 37519 · Supplement to an Abbreviated New Drug Submission (SANDS)
- VERAPAMIL HYDROCHLORIDE INJECTION USPMay 4, 2026 · NOC 37491 · Supplement to a New Drug Submission (SNDS)
- FLUOROURACIL INJECTIONMay 1, 2026 · NOC 37449 · Supplement to a New Drug Submission (SNDS)
- SANDOZ DOLUTEGRAVIRApril 29, 2026 · NOC 37425 · Abbreviated New Drug Submission (ANDS)
- SANDOZ DOLUTEGRAVIRApril 29, 2026 · NOC 37426 · Supplement to an Abbreviated New Drug Submission (SANDS)
- SANDOZ DOLUTEGRAVIRApril 29, 2026 · NOC 37427 · Supplement to an Abbreviated New Drug Submission (SANDS)
- SANDOZ DOLUTEGRAVIRApril 29, 2026 · NOC 37428 · Supplement to an Abbreviated New Drug Submission (SANDS)
- SANDOZ DOLUTEGRAVIRApril 29, 2026 · NOC 37429 · Supplement to an Abbreviated New Drug Submission (SANDS)
- SANDOZ DOLUTEGRAVIRApril 29, 2026 · NOC 37430 · Supplement to an Abbreviated New Drug Submission (SANDS)
- SANDOZ DOLUTEGRAVIRApril 29, 2026 · NOC 37432 · Supplement to an Abbreviated New Drug Submission (SANDS)
- SANDOZ RIVAROXABANApril 27, 2026 · NOC 37408 · Supplement to an Abbreviated New Drug Submission (SANDS)
- SANDOZ CAPECITABINEApril 9, 2026 · NOC 37303 · Supplement to an Abbreviated New Drug Submission (SANDS)
- SANDOZ TACROLIMUS XRMarch 24, 2026 · NOC 37168 · Supplement to an Abbreviated New Drug Submission (SANDS)
- SANDOZ ESTRADIOL DERM 100; SANDOZ ESTRADIOL DERM 50; SANDOZ ESTRADIOL DERM 75March 18, 2026 · NOC 37130 · Supplement to an Abbreviated New Drug Submission (SANDS)
- SANDOZ SILODOSINMarch 18, 2026 · NOC 37138 · Supplement to an Abbreviated New Drug Submission (SANDS)
- SANDOZ BIMATOPROST RCMarch 16, 2026 · NOC 37109 · Supplement to an Abbreviated New Drug Submission (SANDS)
- SANDOZ BIMATOPROSTMarch 16, 2026 · NOC 37110 · Abbreviated New Drug Submission (ANDS)
- SANDOZ BIMATOPROST RCMarch 16, 2026 · NOC 37114 · Supplement to an Abbreviated New Drug Submission (SANDS)
- SUGAMMADEX INJECTIONMarch 3, 2026 · NOC 37018 · Supplement to an Abbreviated New Drug Submission (SANDS)
- ACETYLCYSTEINE SOLUTIONFebruary 27, 2026 · NOC 37005 · Supplement to an Abbreviated New Drug Submission (SANDS)
- AZACITIDINE FOR INJECTIONFebruary 25, 2026 · NOC 36979 · Supplement to an Abbreviated New Drug Submission (SANDS)
- OMNITROPEFebruary 18, 2026 · NOC 36923 · Supplement to a New Drug Submission (SNDS)
- MIDAZOLAM INJECTIONFebruary 18, 2026 · NOC 36957 · Supplement to an Abbreviated New Drug Submission (SANDS)
- SANDOZ LISDEXAMFETAMINE CAPSULESFebruary 9, 2026 · NOC 36862 · Supplement to an Abbreviated New Drug Submission (SANDS)
- LEVETIRACETAM FOR INJECTIONJanuary 21, 2026 · NOC 36766 · Abbreviated New Drug Submission (ANDS)
- SANDOZ AMPHETAMINE XRJanuary 15, 2026 · NOC 36736 · Supplement to a New Drug Submission (SNDS)
- GENTAMICIN INJECTION USPJanuary 7, 2026 · NOC 36690 · Supplement to an Abbreviated New Drug Submission (SANDS)
- SANDOZ CANAGLIFLOZINJanuary 2, 2026 · NOC 36672 · Supplement to an Abbreviated New Drug Submission (SANDS)
- SANDOZ CANAGLIFLOZINJanuary 2, 2026 · NOC 36675 · Supplement to an Abbreviated New Drug Submission (SANDS)
- SANDOZ CANAGLIFLOZINJanuary 2, 2026 · NOC 36676 · Supplement to an Abbreviated New Drug Submission (SANDS)
- SANDOZ CANAGLIFLOZINJanuary 2, 2026 · NOC 36677 · Abbreviated New Drug Submission (ANDS)
- ARSENIC TRIOXIDE FOR INJECTIONDecember 29, 2025 · NOC 36650 · Supplement to an Abbreviated New Drug Submission (SANDS)
- LEUCOVORIN CALCIUM INJECTIONDecember 24, 2025 · NOC 36633 · Supplement to an Abbreviated New Drug Submission (SANDS)
- SANDOZ IRBESARTANDecember 22, 2025 · NOC 36620 · Supplement to an Abbreviated New Drug Submission (SANDS)
- SANDOZ VORICONAZOLE; VORICONAZOLE FOR INJECTIONDecember 22, 2025 · NOC 36707 · Supplement to an Abbreviated New Drug Submission (SANDS)
- ESTRADOTDecember 17, 2025 · NOC 36590 · Supplement to a New Drug Submission (SNDS)
- MEROPENEM FOR INJECTIONDecember 15, 2025 · NOC 36563 · Supplement to an Abbreviated New Drug Submission (SANDS)
- MICRO SEDecember 8, 2025 · NOC 36504 · Supplement to a New Drug Submission (SNDS)
- SANDOZ-CARBAMAZEPINE CRDecember 5, 2025 · NOC 36487 · Supplement to a New Drug Submission (SNDS)
- PANTOPRAZOLE SODIUM FOR INJECTIONDecember 5, 2025 · NOC 36491 · Supplement to an Abbreviated New Drug Submission (SANDS)
- SANDOZ POMALIDOMIDEDecember 5, 2025 · NOC 36550 · Supplement to an Abbreviated New Drug Submission (SANDS)
- SANDOZ GUANFACINE XRDecember 4, 2025 · NOC 36493 · Abbreviated New Drug Submission (ANDS)
- GLYCOPYRROLATE INJECTION USPDecember 2, 2025 · NOC 36476 · Supplement to a New Drug Submission (SNDS)
- SANDOZ ATORVASTATINNovember 16, 2025 · NOC 36485 · Supplement to an Abbreviated New Drug Submission (SANDS)
- MICRO CRNovember 10, 2025 · NOC 36358 · Supplement to a New Drug Submission (SNDS)
- MICRO +4 REGULAR STRENGTHNovember 4, 2025 · NOC 36324 · Supplement to a New Drug Submission (SNDS)
- SANDOZ APIXABAN TABLETNovember 3, 2025 · NOC 36316 · Supplement to an Abbreviated New Drug Submission (SANDS)
- ENZEEVUOctober 30, 2025 · NOC 36288 · New Drug Submission (NDS)
- SANDOZ FINGOLIMODOctober 29, 2025 · NOC 36280 · Supplement to a New Drug Submission (SNDS)
- SANDOZ IRBESARTAN HCTOctober 27, 2025 · NOC 36295 · Supplement to an Abbreviated New Drug Submission (SANDS)
- SANDOZ LEVETIRACETAMOctober 24, 2025 · NOC 36249 · Supplement to an Abbreviated New Drug Submission (SANDS)
- CEFTINOctober 24, 2025 · NOC 36259 · Supplement to a New Drug Submission (SNDS)
- MULTI 12 INJECTIONOctober 23, 2025 · NOC 36243 · Supplement to a New Drug Submission (SNDS)
- MICRO CUOctober 8, 2025 · NOC 36140 · Supplement to a New Drug Submission (SNDS)
- GLYCOPYRROLATE INJECTION USPOctober 7, 2025 · NOC 36147 · Supplement to a New Drug Submission (SNDS)
- HALOPERIDOL LAOctober 5, 2025 · NOC 36124 · Supplement to a New Drug Submission (SNDS)
- SANDOZ ABIRATERONEOctober 3, 2025 · NOC 36108 · Supplement to an Abbreviated New Drug Submission (SANDS)
- CEFTINOctober 3, 2025 · NOC 36115 · Supplement to a New Drug Submission (SNDS)
- SANDOZ LATANOPROSTSeptember 23, 2025 · NOC 36052 · Supplement to an Abbreviated New Drug Submission (SANDS)
- MICRO ZNSeptember 19, 2025 · NOC 36038 · Supplement to a New Drug Submission (SNDS)
- SANDOZ DORZOLAMIDE/TIMOLOLSeptember 17, 2025 · NOC 36028 · Supplement to an Abbreviated New Drug Submission (SANDS)
- SANDOZ LEVOFLOXACINSeptember 12, 2025 · NOC 36000 · Supplement to an Abbreviated New Drug Submission (SANDS)
- SANDOZ ATORVASTATINSeptember 5, 2025 · NOC 35966 · Supplement to an Abbreviated New Drug Submission (SANDS)
The latest 100 of 1,405.
Recalls and safety alerts that mention its products
Health Canada’s recall notices do not carry licence numbers, so these are matched by name. A notice may cover another product or only some lots: read it to see what it covers.
- Two lots of Omnitrope injectable human growth hormone recalled due to cracked cartridgesJuly 8, 2026 · Biologic or vaccine · Product quality · Type I
- Sandoz Anuzinc HC Plus Suppositories (2017-07-17)October 4, 2017 · Drugs · Product safety · Type III
- Anuzinc HC Ointment (2016-01-25)February 2, 2016 · Drugs · Product safety · Type III
- Polytopic Cream (2015-02-19)February 24, 2015 · Drugs · Product safety · Type III
- ACLASTA (zoledronic acid 5 mg/100 mL) - Volume overfill in vials of solution for intravenous infusion - For Health ProfessionalsJuly 8, 2013 · Drugs · Product safety
- Supeudol 20April 23, 2013 · Drugs · Product safety · Type III
- Bisphosphonate osteoporosis drugs (Aclasta, Actonel, Didrocal, Fosamax, Fosavance): Small but increased risk of unusual thigh bone fracturesDecember 19, 2011 · Drugs
- ACLASTA (zoledronic acid 5mg/100mL) solution for intravenous infusion - Association with renal dysfunction - For Health ProfessionalsOctober 14, 2010 · Drugs
- ACLASTA (zoledronic acid 5mg/100mL) solution for intravenous infusion - Association with renal dysfunction - For the PublicOctober 14, 2010 · Drugs